Local news: Abingdon-on-Thames
-
OXIS Energy set to make solid-state Lithium-Sulfur cell technology a reality
The Culham Science Centre based company is set to deploy Solid-State Lithium-Sulfur (Li-S) cell and battery systems to its clients and partners worldwide by Autumn 2021.
-
Vale of White Horse Council and Milton Park to review Local Development Order
Vale of White Horse District Council and MEPC Milton Park have agreed to review the Local Development Order (LDO) to help bring more sustainable investment to the Park.
-
Abingdon based West Waddy merges with Archadia Architects
Award-winning multidisciplinary architecture, planning and urban design Practices – West Waddy ADP and Archadia Architects – have merged to form a new Practice, WWA.
-
Thames Travel unveils new Milton Park buses livery
Thames Travel has launched its newly branded Milton Park buses as part of a partnership with Milton Park following substantial improvements to bus connectivity
-
Exhibition launched on plans for A34 junction at Lodge Hill
Residents in the Abingdon area and users of the nearby A34 are set to benefit from major road improvements with plans to build a new south-facing slip road at Lodge Hill.
-
Emergex Vaccines expands at Milton Park
Emergex Vaccines, which focuses on the development of synthetic T-cell vaccines against global infectious disease threats has expanded at Milton Park.
-
Tokamak Energy signs agreement with Switzerland’s Paul Scherrer Institute
Tokamak Energy’s proprietary non-insulated high temperature superconducting (HTS) magnet technology will be used in PSI’s accelerator and beam line applications.
-
Evotec expands again at Milton Park
Evotec’s latest expansion at 95 Park Drive, which totals 43,141 sq ft across three floors, is in addition to the 16,823 sq ft at 90 Park Drive it took in September 2020.
-
Immunocore closes $75m Series C private financing round
Led by an existing investor, the funding follows positive Phase 3 trial interim analysis data for tebentafusp in patients with metastatic uveal melanoma.
-
PerkinElmer to acquire Abingdon-based Oxford Immunotec
Under the terms of the Acquisition, Oxford Immunotec shareholders will be entitled to receive $22.00 in cash for each outstanding ordinary share.
-
Oxford Instruments delivers Proteox to Oxford Quantum Circuits
Oxford Quantum Circuits (OQC) is taking delivery of Oxford Instruments’ next-generation Cryofree® refrigerator, Proteox.
-
Abingdon-based Scientific Magnetics to merge with Australian Magnetica
The merger completion is subject only to Magnetica’s shareholder approval at an upcoming General Meeting on 29 January.